Karen Burke is a Clinical Professor and research scientist in the Department of Dermatology at Mt. Sinai Medical Center (NY, NY) with a private practice in dermatology. After her Ph.D. in biophysics at Cornell University and post-doctoral research at Weill Cornell Medical College and The Rockefeller University, she completed her M.D. with Dermatology Residency at New York University. Dr. Burke’s past research has focused primarily on topical and oral antioxidants to prevent and reverse photoaging and to prevent skin cancer. Her current research is exciting new cellular immunotherapy, collaborating in a clinical Phase I study first to treat stage IV melanoma, lung cancer, and pancreatic cancer before including multiple other types of cancer.
Dr. Burke is an Honorary Life Governor of the NY Academy of Sciences, serves on the Board of Directors of the NY Stem Cell Foundation and the Parkinson’s Foundation, and is on the US FDA Surgery Device Advisory Panel. She is founder and president of the Karen E. Burke Research Foundation and of Longévité, Ltd. Dr. Burke responded, “It is an honor to join this board, and I am thrilled to do so alongside two remarkable leaders in their fields. Through the innovative research made possible by NFCR, I am certain that our shared hope and vision for cancer treatment and cure will indeed become a reality in the near future.”
